Skip to main content

Table 5 MVA of the progression-free rate

From: Galectin-1 is a poor prognostic factor in patients with glioblastoma multiforme after radiotherapy

Parameter p value HR (95% CI)
Age (≥ 50 vs. <  50 years) 0.159 2.369 (0.712–7.878)
Gender (male vs. female) 0.114 0.320 (0.078–1.312)
ECOG (3–4 vs 0–2) 0.258 2.292 (0.544–9.650)
Size (≥ 5 cm vs. <  5 cm) 0.819 1.213 (0.232–6.350)
OP method (non-gross total vs. gross total) 0.023 7.408 (1.320–41.585)
RT field (whole brain vs. small) 0.609 0.716 (0.202–2.535)
Galectin-1 (strong vs. weak) 0.037 6.080 (1.113–33.219)
Galectin-3 (strong vs. weak) 0.089 0.181 (0.025–1.299)
  1. MVA multivariate statistical analysis, ECOG Eastern Cooperative Oncology Group, OP operation, RT radiotherapy